Coxsackie B virus

Electron micrograph of Coxsackie B4 virus

The Coxsackie B virus is a member of the Enterovirus genus, which is part of the Picornaviridae family. It is a non-enveloped, positive-sense single-stranded RNA virus. The Coxsackie B virus is known for causing a variety of diseases in humans, ranging from mild respiratory infections to more severe conditions such as myocarditis and meningitis.

Virology

Coxsackie B viruses are small, icosahedral viruses with a diameter of approximately 30 nm. They possess a single-stranded RNA genome of about 7,500 nucleotides. The genome encodes a single polyprotein that is cleaved into structural and non-structural proteins. The structural proteins form the viral capsid, which protects the RNA genome and facilitates entry into host cells.

Transmission

Coxsackie B viruses are primarily transmitted via the fecal-oral route, but they can also spread through respiratory droplets and contact with contaminated surfaces. The virus is highly contagious, especially in crowded environments such as schools and daycare centers.

Clinical Manifestations

Coxsackie B virus infections can lead to a wide range of clinical manifestations:

• Herpangina: Characterized by fever, sore throat, and vesicular lesions in the oral cavity.
• Hand, foot, and mouth disease: A common illness in children, presenting with fever, sore throat, and a rash on the hands, feet, and mouth.
• Myocarditis: Inflammation of the heart muscle, which can lead to heart failure.
• Pericarditis: Inflammation of the pericardium, the fibrous sac surrounding the heart.
• Meningitis: Inflammation of the protective membranes covering the brain and spinal cord.

Diagnosis

Diagnosis of Coxsackie B virus infection is typically based on clinical presentation and can be confirmed by laboratory tests such as polymerase chain reaction (PCR) to detect viral RNA, or by isolating the virus from throat swabs, stool samples, or cerebrospinal fluid.

Treatment

There is no specific antiviral treatment for Coxsackie B virus infections. Management is primarily supportive, focusing on relieving symptoms such as fever and pain. In severe cases, hospitalization may be required for complications like myocarditis or meningitis.

Prevention

Preventive measures include practicing good hygiene, such as regular handwashing, and avoiding close contact with infected individuals. There is currently no vaccine available for Coxsackie B virus.

Related pages

• Enterovirus
• Picornaviridae
• Myocarditis
• Meningitis